Table 6.

Alagille Syndrome: Treatment of Manifestations

Manifestation/ConcernTreatmentConsiderations/Other
Pruritus & xanthomas Choleretic agents (ursodeoxycholic acid), ileal bile acid transport inhibitors, & other medications (cholestyramine, rifampin, naltrexone)Combination of therapies often required; biliary diversion may be performed for severe pruritus refractory to medical therapy.
Refractory cholestasis /
End-stage liver disease
Liver transplantationA liver specialist familiar w/ALGS is recommended in the treatment of hepatic manifestations.
Hepatocellular carcinoma Standard treatments per hepatologist/oncologist
Poor growth Optimized nutrition; replacement of fat-soluble vitamins as neededNasogastric feeds or gastrostomy tube may be required to maintain caloric intake.
Cardiovascular manifestations Treatment per cardiologist & cardiothoracic surgeon at center w/experience in treatment of ALGS 1
Ophthalmologic/
Vision
Low vision services as needed for those w/loss of visual functionOcular issues in those w/ALGS rarely require treatment, as visual prognosis is good. However, some persons have peripheral chorioretinal changes incl atrophy (w/accompanying loss of function in the visual field) & other retinal pigmentary changes, macular atrophy, & progressive decrease in vision.
Renal manifestations Treatment as needed per nephrologist
Neurodevelopmental manifestations Developmental & educational support as needed

ALGS = Alagille syndrome

1.

From: Alagille Syndrome

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.